Amiodarone-Induced Myxedema Coma
- PMID: 32850263
- PMCID: PMC7444890
- DOI: 10.7759/cureus.9902
Amiodarone-Induced Myxedema Coma
Abstract
Amiodarone is a class III antiarrhythmic drug often used to treat supraventricular and ventricular arrhythmias with high efficacy. Amiodarone is associated with thyroid dysfunction, which can lead to myxedema coma (MC) in undiagnosed cases. Amiodarone-induced MC is a life-threatening condition that presents a complex diagnostic challenge to emergency physicians. A 71-year-old male with a past medical history of congestive heart failure presented unresponsive to the emergency department with bradycardia and syncope. His medications included amiodarone. Work-up showed hypothermia, thyroid-stimulating hormone (TSH) of 52.2 uIU/mL, and low free T4 of 0.64 ng/dL. This case suggests the importance of thyroid panels in the management of patients who are using amiodarone long-term. This case also highlights a simple and effective treatment for amiodarone-induced MC.
Keywords: amiodarone; hypothyroidism; levothyroxine; myxedema coma.
Copyright © 2020, Raeouf et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Amiodarone as paradigm for developing new drugs for atrial fibrillation. Singh BN. J Cardiovasc Pharmacol. 2008;52:300–305. - PubMed
-
- Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Bogazzi F, Bartalena L, Dell'Unto E, et al. Clin Endocrinol. 2007;67:533–537. - PubMed
-
- Thyroid emergencies. Sarlis NJ, Gourgiotis L. Rev Endocr Metab Disord. 2003;4:129–136. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous